NEI Research News

NEI researcher Mitra Farnoodian Tedrick, Ph.D., received a $65,000 grant from the Knights Templar Eye Foundation (KTEF) to identify drugs to treat a rare blinding condition called Stargardt disease.

A new report outlines progress toward the National Eye Institute's Audacious Goals Initiative (AGI), an effort to restore vision through research in regenerative medicine. The report, published in Nature Medicine.

Johns Hopkins Medicine researchers say they have found that levels of a specific protein appears to help accurately predict whether people with the wet form of age-related macular degeneration may need lifelong, frequent eye injections to preserve vision.

A new study reveals how photoreceptors grown from stem cells might extend biological wires, known as axons, to contact existing neurons.

New findings about how the brain interprets sensory information may have applications for treating brain disorders and designing artificial intelligence.

The size of our primary visual cortex and the amount of brain tissue we have dedicated to processing visual information can predict how well we can see, a new study shows.

New research from the University of Alabama at Birmingham Marnix E. Heersink School of Medicine is shining a light on whether vision screenings for older drivers identify those who are likely to have motor vehicle collisions in the next few years.

Researchers from the National Eye Institute (NEI) have identified a new disease that affects the macula, a small part of the light-sensing retina needed for sharp, central vision.

Researchers from the Buck Institute have demonstrated for the first time a link between diet, circadian rhythms, eye health and lifespan.

The AREDS2 formula not only reduces risk of lung cancer due to beta-carotene, but is also more effective at reducing risk of AMD progression, compared to the original formula.